Why you should consider TMS & Esketamine Therapy for Depression
According to recent data major depression affects more than 8% of the American population. Although treatable, lifelong depression can become a reality for some. For patients suffering from treatment-resistant depression where psychotherapy and antidepressants don’t work, treatments like Eskatamine and TMS can be life-changing.
What is TMS?
Transcranial magnetic stimulation (TMS) is a revolutionary therapy that involves brain stimulation, a treatment beneficial for patients who haven’t been able to find relief with antidepressants and counselling. TMS is a non-invasive brain stimulation treatment that uses magnetic fields to stimulate nerve cells in the brain, providing relief from the symptoms of depression.
How is TMS superior to other Depression treatments?
- Since TMS doesn’t involve administering any drug the side effects that apply to common antidepressants are completely avoided.
- As the procedure is non-invasive it does not require any anaesthesia or sedation of the patient. The patient undergoing the treatment remains fully awake and alert throughout the duration of the therapy.
2 out of 3 patients experienced a significant improvement in depression symptoms and 50% experienced a complete remission after undergoing the TMS therapy.
How does TMS work?
After an initial evaluation and understanding of your depression symptoms your medical healthcare provider will ascertain if TMS is a suitable treatment for you. The therapy is similar to any outpatient procedure as sessions usually last for 20 minutes. Ohio Psychiatric Services has a team of specialists who are present during this duration and can help you with any query related to the treatment.
During the session, the patient sits in a comfortable TMS chair, during which they can watch TV or read a book. Given the non-invasive nature of the therapy, there is no post process of recuperation needed, you can carry on with your daily activities after the completion of the session. However one must note that the patient must undergo at least 36 sessions to expect a long-term and sustainable relief from the symptoms.
Esketamine Therapy for Depression
Another therapy for patients who experience treatment-resistant depression is Ketamine. A nasal spray Esketamine or Spravato™ (derived from Ketamine) was recently approved by the FDA for treating depression. The drug similar to a nasal decongestant has proved to provide relief to patients who haven’t seen results with other treatments for depression.
How is Spravato™ superior to other Depression treatments?
Esketamine or Spravato™ unlike antidepressants doesn’t work by increasing the levels of chemicals like serotonin or dopamine in the brain. It increases glutamate, the most abundant chemical messenger present in our brain.
70% of patients who received Esketamine along with other antidepressants saw a 50% reduction in symptoms of depression. 50% of patients experienced remission of symptoms of depression.
How does Esketamine Therapy work?
The patient receives the drug at our centre under the supervision of our healthcare specialist. Our team observes the patient for two hours for any possible side effects. Some patients may experience headaches, dizziness or nausea after taking the treatment. A healthcare specialist is present with the patient to assist them if they experience any side effects after undergoing the Esketamine therapy.
70% of patients who received Esketamine along with other antidepressants saw a 50% reduction in symptoms of depression. 50% of patients experienced remission of symptoms of depression.
Which treatment is better for me?
Spravato™ or Esketamine and TMS are treatment options aimed at providing relief to patients who haven’t seen encouraging results with traditional depression treatments. Your mental healthcare provider after understanding your symptoms, and medical history can help you plan the best treatment option for you. Ohio Psychiatric Services is well-equipped to provide you with the best-customized treatment that can help you lead a healthy life. Reach out to our specialist today.
70% of patients who received Esketamine along with other antidepressants saw a 50% reduction in symptoms of depression. 50% of patients experienced remission of symptoms of depression.
Summary
Spravato™ or Esketamine and TMS are treatment options aimed at providing relief to patients who haven’t seen encouraging results with traditional depression treatments.